Media Resources

Press & Media

Everything journalists need to cover The Reversal Initiative. Story angles, assets, and direct contact information.

Press Release Summary

The Reversal Initiative is a self-funded, open-source project building AI-powered computational drug discovery tools to fight Alzheimer's disease. Founded by David Scott Lewis (former META EVP, 20+ peer-reviewed papers) and Enrique Zueco (CTO, AI-Scientist v2 architect), the initiative provides 37+ production-ready modules for researchers worldwide.

The project was inspired by a January 2026 Cell Reports Medicine paper (DOI: 10.1016/j.xcrm.2025.102535) demonstrating that P7C3-A20, an NAD+ pathway activator, reversed Alzheimer's pathology in mice. The Reversal Initiative builds the computational bridge between this preclinical breakthrough and potential human therapies.

The team has published 14 peer-reviewed papers and presented at AAAI-26 and NeurIPS. The platform runs on standard hardware and is designed for researchers who cannot afford commercial computational platforms.

Five Ways to Tell This Story

Personal Interest

A tech executive's mother died from Alzheimer's. His sister was diagnosed 18 months ago. Now he's building the tools he wishes existed.

Science & Technology

Scientists reversed Alzheimer's in mice. An AI team is building the open-source bridge to human therapies using 37+ computational modules.

Crowdfunding Innovation

A grassroots campaign to democratize drug discovery. For 25 euros, you can screen 5,000 molecules against Alzheimer's targets.

Open Science Movement

Why locking research tools behind $500K paywalls slows down the fight against the world's most costly disease.

Democratizing Drug Discovery

How AI and open-source code could give every lab in the world access to tools that were once reserved for big pharma.

Downloadable Assets

Photos

High-resolution founder photos and team imagery (coming soon)

Logo

Initiative and AIXC logos in SVG, PNG, and EPS formats (coming soon)

One-Pager

Single-page summary with key facts and figures (coming soon)

Media Contact

For interviews, comments, or additional information:

press@aixc.bio

We typically respond to press inquiries within 12 hours.

Request Full Press Kit

Get the complete media package including high-res assets, fact sheet, founder bios, and interview availability.

Request Press Kit